Flu News and Research

RSS

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States.

16 Sep 2015

UTHealth's Paula Stigler-Granados awarded grant to conduct outreach, education on Chagas disease in South Texas

A researcher at The University of Texas Health Science Center at Houston School of Public Health was awarded a five-year, $544,329 grant from the Centers for Disease Control and Prevention to conduct outreach and education on Chagas disease in South Texas.

14 Sep 2015

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

Healthy adults who get the flu vaccine may help protect not only themselves but also older adults in their community at higher risk for serious complications from influenza, suggest findings from a new study published in Clinical Infectious Diseases. Based on a national sample of more than 3 million people across eight flu seasons, researchers observed that seniors were up to 21 percent less likely to be diagnosed with flu-related illness if they lived in areas where more adults under 65 were immunized.

10 Sep 2015

New nanozyme test can help curb Ebola spread in western Africa

A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.

10 Sep 2015

Mesothelioma website provides three new tips to combat disease

Mesothelioma.us, a free online resource that features comprehensive resources for people who have been diagnosed with mesothelioma, has just unveiled three new tips for beating the disease.

4 Sep 2015

Early antiviral treatment reduces disability risk, hospitalization time in older people

Early treatment of flu-hospitalized people 65 and older with flu antiviral medications cuts the duration of their hospital stay and reduces their risk of needing extended care after discharge, a new CDC study finds.

4 Sep 2015

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced that its Focus Diagnostics products business has received FDA 510(k) clearance to add the genital swab claim to its Simplexa HSV 1 & 2 Direct molecular test on the Integrated Cycler.

From Quest Diagnostics 4 Sep 2015

New technology may allow mass production of flu vaccines

Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today (Sept. 2) by researchers at the University of Wisconsin-Madison in the journal Nature Communications.

3 Sep 2015

Volatile anesthetics may combat viral and bacterial infections in the lung

In use for more than a century, inhaled anesthetics like nitrous oxide and halothane have made modern surgery possible. Now, in experiments in mice, researchers at Johns Hopkins and elsewhere have added to evidence that certain so-called "volatile" anesthetics -- commonly used during surgeries -- may also possess powerful effects on the immune system that can combat viral and bacterial infections in the lung, including influenza and pneumonia.

2 Sep 2015

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Passport Health, in partnership with vaccine manufacturer PaxVax, Inc. is participating in a clinical study to test the effects of the oral typhoid vaccination, Vivotif (Typhoid Vaccine Live Oral Ty21a). The study will look at the side effects that could occur when taking Vivotif across the range of approved potencies.

28 Aug 2015

Many primary care physicians overestimate their ability to assess Ebola risks in patients

While most primary care physicians responding to a survey taken in late 2014 and early 2015 expressed confidence in their ability to identify potential cases of Ebola and communicate Ebola risks to their patients, only 50 to 70 percent of them gave answers that fit with CDC guidelines when asked how they would care for hypothetical patients who might have been exposed to Ebola.

28 Aug 2015

Founder of ACPA discusses how patient with chronic pain can tackle their NSAID usage

When a patient with chronic pain is experiencing symptoms, relief is only thing on their mind. NSAIDs, or nonsteroidal anti-inflammatory drugs, can often provide that relief, however it's important to balance the potential benefits with the potential risks of these drugs.

27 Aug 2015

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes a case-series of eight British health-care workers who were evacuated to the Royal Free Hospital in London, UK after possible accidental exposure to Ebola virus in Sierra Leone between January and March 2015.

26 Aug 2015

Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

26 Aug 2015

Flu remedies can help treat E. coli bacteria

If the intestinal bacteria level becomes unbalanced, it can cause diseases. Physiologists from the University of Zurich reveal how a specific carbohydrate in the intestinal mucosa heavily multiplies certain E. coli bacteria and thus causes inflammations. These could be treated with flu remedies, which opens up new therapeutic possibilities.

26 Aug 2015

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia Pharmaceuticals, Inc. today announced the initiation of enrollment of children as young as 6 years old in the company's ongoing Phase 2 study of palovarotene for the treatment of fibrodysplasia ossificans progressiva (FOP).

26 Aug 2015

Study: Influenza vaccines offer sustained protection up to 6 months during flu season

Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases.

25 Aug 2015

New study affirms value of influenza vaccination among older people

A new study of the records of millions of nursing home residents affirms the value of influenza vaccination among the elderly. The Brown University analysis found that between 2000 and 2009, the better matched the vaccine was for the influenza strain going around, the fewer nursing home residents died or were hospitalized.

25 Aug 2015

TSRI, Janssen collaborate to find universal flu vaccine

Scientists from The Scripps Research Institute and the Janssen Pharmaceutical Companies of Johnson & Johnson have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

24 Aug 2015

60P to commence Phase II clinical trial among dengue fever patients

60 Degrees Pharmaceuticals, a company focused on development of therapeutics for tropical diseases, and Singapore General Hospital announced today that the Hospital has received a grant from Singapore's National Medical Research Council to support a Phase II clinical trial among dengue fever patients.

20 Aug 2015

Flu News and Research

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

UTHealth's Paula Stigler-Granados awarded grant to conduct outreach, education on Chagas disease in South Texas

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

New nanozyme test can help curb Ebola spread in western Africa

Mesothelioma website provides three new tips to combat disease

Early antiviral treatment reduces disability risk, hospitalization time in older people

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

New technology may allow mass production of flu vaccines

Volatile anesthetics may combat viral and bacterial infections in the lung

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Many primary care physicians overestimate their ability to assess Ebola risks in patients

Founder of ACPA discusses how patient with chronic pain can tackle their NSAID usage

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Flu remedies can help treat E. coli bacteria

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Study: Influenza vaccines offer sustained protection up to 6 months during flu season

New study affirms value of influenza vaccination among older people

TSRI, Janssen collaborate to find universal flu vaccine

60P to commence Phase II clinical trial among dengue fever patients

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News